Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Cancer Research|November 3, 2006
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogrammingKristiina Iljin, Maija Wolf, Henrik Edgren, et al.
Bioinformatics (Oxford, England)|March 3, 2020
Breeze: an integrated quality control and data analysis application for high-throughput drug screeningSwapnil Potdar, Aleksandr Ianevski, John-Patrick Mpindi, et al.
European Urology|January 4, 2015
miR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigenOlivia Larne, Päivi Östling, Benedikta S Haflidadóttir, et al.
Frontiers in Oncology|July 7, 2022
Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid MesotheliomaHely Ollila, Mikko I Mäyränpää, Lassi Paavolainen, et al.
Molecular Oncology|May 31, 2017
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumorsMatthias Kolberg, Jarle Bruun, Astrid Murumägi, et al.
Breast Cancer (Dove Medical Press)|March 31, 2017
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment responseSandra Jernström, Vesa Hongisto, Suvi-Katri Leivonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistanceJonna Nevo, Elina Mattila, Teijo Pellinen, et al.
Genome Biology|January 21, 2011
Identification of fusion genes in breast cancer by paired-end RNA-sequencingHenrik Edgren, Astrid Murumagi, Sara Kangaspeska, et al.
Carcinogenesis|April 28, 2009
Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpointAnna-Leena Salmela, Jeroen Pouwels, Asta Varis, et al.
The Prostate|September 16, 2011
Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancerPaula Vainio, Maija Wolf, Henrik Edgren, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Cancer Research|November 3, 2006
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogrammingKristiina Iljin, Maija Wolf, Henrik Edgren, et al.
Bioinformatics (Oxford, England)|March 3, 2020
Breeze: an integrated quality control and data analysis application for high-throughput drug screeningSwapnil Potdar, Aleksandr Ianevski, John-Patrick Mpindi, et al.
European Urology|January 4, 2015
miR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigenOlivia Larne, Päivi Östling, Benedikta S Haflidadóttir, et al.
Frontiers in Oncology|July 7, 2022
Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid MesotheliomaHely Ollila, Mikko I Mäyränpää, Lassi Paavolainen, et al.
Molecular Oncology|May 31, 2017
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumorsMatthias Kolberg, Jarle Bruun, Astrid Murumägi, et al.
Breast Cancer (Dove Medical Press)|March 31, 2017
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment responseSandra Jernström, Vesa Hongisto, Suvi-Katri Leivonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistanceJonna Nevo, Elina Mattila, Teijo Pellinen, et al.
Genome Biology|January 21, 2011
Identification of fusion genes in breast cancer by paired-end RNA-sequencingHenrik Edgren, Astrid Murumagi, Sara Kangaspeska, et al.
Carcinogenesis|April 28, 2009
Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpointAnna-Leena Salmela, Jeroen Pouwels, Asta Varis, et al.
The Prostate|September 16, 2011
Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancerPaula Vainio, Maija Wolf, Henrik Edgren, et al.
Pageof 19